Bode John B bought ZVRA

March 24, 2026 · Form 4 insider transaction

Bode John B bought 39,200 shares of Zevra Therapeutics, Inc. at $4.97 per share, a transaction worth $194.8K. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.